AngloGold Ashanti
AU
90.05
-3.50
-3.74%
AngloGold Ashanti
US · AU
#464 by market cap
Listed 1970
90.05
-3.50
-3.74%
Live - 5344 symbols - heartbeat 96s ago
· 2026-10-08 06:44
Pre-market
88.47
-1.75%
After-hours
90.09
+0.04%
Overnight
88.87
-1.31%
- Market cap
- 45.54B
- P/E (TTM)i
- 12.07
- P/Bi
- 5.08
- EPSi
- 5.18
- Div yieldi
- 5.11%
- 52W posi
- 47%
Reader sentiment
Are you bullish or bearish on AU?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.13, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +70.78% YoY
Margins
- Gross margin
- 49.24%
- Operating margin
- 43.15%
- Net margin
- 26.65%
Key ratios & quality
- Enterprise valuei
- 44.77B
- PEG ratioi
- 0.10
- Altman Z-Scorei
- 7.13
PEG uses trailing P/E against the 3-year net income growth rate (124.49%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.34B | 3.53B | 4.60B | 4.03B | 4.50B | 4.58B | 5.79B | 9.89B |
| Gross profit | 750.00M | 904.00M | 1.75B | 1.17B | 1.13B | 1.03B | 2.07B | 4.87B |
| Selling & admin expenses | 102.00M | 102.00M | 85.00M | 90.00M | 87.00M | 99.00M | 162.00M | 151.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 497.00M | 611.00M | 1.50B | 797.00M | 833.00M | 574.00M | 1.55B | 4.27B |
| Pretax profit | 445.00M | 619.00M | 1.63B | 949.00M | 472.00M | 63.00M | 1.67B | 4.28B |
| Tax | 212.00M | 250.00M | 625.00M | 311.00M | 221.00M | 285.00M | 623.00M | 1.10B |
| Net profit | 150.00M | -7.00M | 1.01B | 638.00M | 251.00M | -222.00M | 1.05B | 3.17B |
| Basic EPS | 0 | 0 | 2 | 1 | 1 | -1 | 2 | 5 |
| Diluted EPS | 0.32 | -0.03 | 2.36 | 1.46 | 0.55 | -0.56 | 2.33 | 5.18 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.96B | 2.45B | 2.42B | 3.07B | 3.24B | 3.10B |
| Gross profit | 839.00M | 1.20B | 1.19B | 1.64B | 1.94B | 1.70B |
| Selling & admin expenses | 27.00M | 34.00M | 32.00M | 58.00M | 44.00M | 45.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 747.00M | 999.00M | 1.03B | 1.50B | 1.81B | 1.58B |
| Pretax profit | 729.00M | 1.05B | 1.06B | 1.44B | 1.95B | 1.66B |
| Tax | 187.00M | 240.00M | 242.00M | 433.00M | 487.00M | 468.00M |
| Net profit | 542.00M | 806.00M | 815.00M | 1.01B | 1.46B | 1.19B |
| Basic EPS | 1 | 1 | 1 | 2 | 3 | 2 |
| Diluted EPS | 0.88 | 1.32 | 1.31 | 1.68 | 2.51 | 1.96 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.23B | 1.98B | 2.33B | 2.14B | 2.15B | 2.17B | 3.15B | 4.65B |
| Cash & ST investments | 335.00M | 466.00M | 1.33B | 1.15B | 1.11B | 964.00M | 1.43B | 2.91B |
| Inventory | 652.00M | 632.00M | 733.00M | 703.00M | 773.00M | 829.00M | 1.06B | 1.08B |
| Total assets | 6.64B | 6.86B | 7.71B | 8.01B | 8.01B | 8.26B | 13.23B | 15.08B |
| Total current liabilities | 793.00M | 1.44B | 959.00M | 827.00M | 884.00M | 1.29B | 1.53B | 1.62B |
| Short-term debt | 139.00M | 779.00M | 179.00M | 112.00M | 91.00M | 289.00M | 187.00M | 101.00M |
| Long-term debt | 1.91B | 1.30B | 1.79B | 1.86B | 1.97B | 2.03B | 1.90B | 2.03B |
| Total liabilities | 3,949,000,000.00 | 4,187,000,000.00 | 3,932,000,000.00 | 3,906,000,000.00 | 3,938,000,000.00 | 4,517,000,000.00 | 4,717,000,000.00 | 5,162,000,000.00 |
| Total equity | 2.69B | 2.68B | 3.77B | 4.10B | 4.08B | 3.74B | 8.51B | 9.92B |
| Retained earnings | -- | -- | -- | -- | -1.77B | -2.15B | -1.32B | 76.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 3.22B | 4.01B | 4.54B | 4.65B | 4.79B | 4.53B |
| Cash & ST investments | 1.49B | 2.00B | 2.55B | 2.91B | 3.15B | 2.78B |
| Inventory | 1.06B | 1.03B | 1.06B | 1.08B | 1.05B | 1.06B |
| Total assets | 13.39B | 14.13B | 14.84B | 15.08B | 15.71B | 15.55B |
| Total current liabilities | 1.37B | 1.34B | 1.76B | 1.62B | 1.77B | 1.67B |
| Short-term debt | 191.00M | 167.00M | 164.00M | 101.00M | 112.00M | 76.00M |
| Long-term debt | 1.93B | 2.02B | 2.03B | 2.03B | 2.02B | 1.56B |
| Total liabilities | 4,714,000,000.00 | 4,838,000,000.00 | 5,282,000,000.00 | 5,162,000,000.00 | 5,327,000,000.00 | 4,814,000,000.00 |
| Total equity | 8.68B | 9.29B | 9.55B | 9.92B | 10.38B | 10.74B |
| Retained earnings | 6.24B | 6.87B | 7.14B | 76.00M | 7.97B | 8.39B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 857.00M | 1.05B | 1.69B | 1.27B | 1.80B | 971.00M | 1.97B | 4.78B |
| Depreciation & amortization | 558.00M | 583.00M | 575.00M | -- | 637.00M | 658.00M | 752.00M | 1.29B |
| Free cash flow | 282.00M | 344.00M | 952.00M | 240.00M | 776.00M | -71.00M | 878.00M | 3.34B |
| Dividends paid | -39.00M | -43.00M | -47.00M | -240.00M | -203.00M | -107.00M | -244.00M | -1.87B |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 329.00M | 456.00M | 1.33B | 1.15B | 1.11B | 955.00M | 1.40B | 2.88B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 725.00M | 1.02B | 1.42B | 1.62B | 1.71B | 1.43B |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | 422.00M | 668.00M | 1.08B | 1.17B | 1.28B | 945.00M |
| Dividends paid | -427.00M | -212.00M | -562.00M | -670.00M | -1.03B | -827.00M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 1.46B | 1.99B | 2.53B | 2.88B | 3.13B | 2.77B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 5.00 | -0.26 | 30.66 | 16.77 | 7.79 | -6.02 | 19.42 | 35.82 |
| ROA %i | 1.92 | -0.10 | 13.36 | 8.26 | 3.94 | -2.89 | 9.41 | 18.67 |
| ROIC %i | 5.10 | 1.79 | 19.73 | 11.46 | 5.73 | -3.50 | 13.52 | 28.08 |
| 5-year avg ROE %i | -0.58 | -0.24 | 6.63 | 9.30 | 11.73 | 9.38 | 13.32 | 14.15 |
| EBIT margin %i | 11.39 | 22.33 | 39.37 | 26.51 | 14.00 | 4.67 | 31.64 | 45.40 |
| FCF / sales %i | 5.20 | 9.76 | 21.50 | 5.96 | 17.24 | -- | 15.16 | 33.71 |
| Current ratioi | 1.55 | 1.38 | 2.43 | 2.59 | 2.43 | 1.69 | 2.06 | 2.87 |
| Quick ratioi | 0.69 | 0.50 | 1.63 | 1.66 | 1.46 | 0.98 | 1.30 | 2.07 |
| Debt / assetsi | 30.86 | 32.11 | 27.05 | 26.15 | 27.09 | 29.30 | 16.27 | 15.13 |
| LT debt / equityi | 72.06 | 53.98 | 51.10 | 48.97 | 51.49 | 57.40 | 29.66 | 26.94 |
| Interest coveragei | 2.63 | 4.68 | 11.32 | 9.71 | 4.47 | 1.42 | 11.39 | 20.89 |
| Revenue CAGR (3Y) %i | -5.99 | -5.84 | 10.63 | 6.49 | 8.49 | -0.09 | 12.87 | 30.02 |
| Net income CAGR (3Y) %i | -- | -- | -- | 59.97 | -- | -- | 17.81 | 124.49 |
| FCF CAGR (3Y) %i | -15.78 | -10.20 | 43.52 | -5.23 | 31.15 | -- | 54.09 | 62.58 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 20.50 | 31.74 | 38.10 | 35.82 | 45.39 | 46.50 |
| ROA %i | 10.37 | 16.05 | 19.05 | 18.67 | 23.88 | 25.65 |
| ROIC %i | 15.57 | 22.80 | 27.88 | 28.08 | 35.89 | 37.99 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 36.39 | 39.60 | 43.51 | 45.40 | 51.59 | 53.85 |
| FCF / sales %i | 19.56 | 23.35 | 29.43 | 33.71 | 37.56 | 37.81 |
| Current ratioi | 2.34 | 2.99 | 2.58 | 2.87 | 2.71 | 2.71 |
| Quick ratioi | 1.55 | 1.98 | 1.83 | 2.07 | 2.06 | 2.03 |
| Debt / assetsi | 16.77 | 16.36 | 15.60 | 15.13 | 14.56 | 11.51 |
| LT debt / equityi | 30.34 | 28.92 | 27.97 | 26.94 | 25.47 | 19.15 |
| Interest coveragei | 14.79 | 18.70 | 18.56 | 20.89 | 21.82 | 24.68 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Gold income is the largest reported line at 97.74% of revenue, across 2 reported segments.
- The next-largest line, By-products, is a distant second at 2.26% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Gold income97.74%
By-products2.26%
Quote time 2026-10-08 06:44:42 · For reference only, not investment advice and not tailored to your situation.